Which is better, BSX or MMM?

On the Buffett-Fit framework, Boston Scientific Corporation (BSX) currently grades higher than MMM — 57/100 (C grade) vs 32/100 (F). That said, "better" depends on which framework you trust — BSX wins on Warren Buffett, Philip Fisher, Peter Lynch, Joel Greenblatt, Charlie Munger, and Terry Smith; MMM wins on none. The full pillar breakdown is on this page.

Should I buy BSX or MMM?

This page is an educational comparison, not investment advice. Both BSX and MMM are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is BSX better than MMM for value investing?

On the Buffett-style value-investing framework, BSX currently grades higher — 57/100 vs 32/100, a 25-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between BSX and MMM on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). BSX currently scores 57/100 (C grade); MMM scores 32/100 (F grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, BSX or MMM?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. BSX and MMM are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, BSX or MMM?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Can you compare BSX (Healthcare) and MMM (Industrials) directly?

BSX is a Healthcare stock and MMM is in Industrials, so this is a cross-sector comparison. The Buffett-Fit scoring on this page applies sector-relative bonuses to each stock against its own sector benchmarks, so the cross-sector comparison is still meaningful — but for the cleanest like-for-like, sector peers usually compare better than cross-sector pairs.

Is this BSX vs MMM comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Boston Scientific

3M

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

BSX

Boston Scientific

Market cap

$78.3B

Sector

Healthcare

MMM

Market cap

$76.26B

Sector

Industrials

Overall winner

Boston Scientific BSX

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	BSX	MMM	Winner
Warren Buffett	57C	32F	BSX
Benjamin Graham	63C	63C	Tie

Side-by-side metrics

Metric	BSX	MMM
Market cap	$78.3B	$76.26B
P/E (TTM)	22.0x	27.8x
EV/EBIT	22.1x	18.6x
ROIC (TTM)	9.9%	13.02%
Gross margin	70.41%	39.51%
Net margin	17.24%	11.14%
Revenue CAGR 5y	13.99%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

BSX leads on

Revenue CAGR 5y13.99%vs -8.35%+160%
EPS CAGR 5y29.71%vs -12.34%+142%
Debt / Equity0.4xvs 3.8x+89%
Gross margin70.41%vs 39.51%

More like BSX

BSX vs IDXX BSX vs LMAT BSX vs MTD BSX vs HALO BSX vs HRMY BSX vs RPRX

More like MMM

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.